1,222
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study

, , , , &
Pages 22-27 | Accepted 10 Jul 2013, Published online: 01 Nov 2013

References

  • Ostensen M, Aune B, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983;12:69–72.
  • Pikwer M, Bergstrom U, Nilsson JA, Jacobsson L, Turesson C. Early menopause is an independent predictor of rheumatoid arthritis. Ann Rheum Dis 2012;71:378–81.
  • Tan AL, Emery P. Role of oestrogen in the development of joint symptoms? Lancet Oncology 2008;9:817–18.
  • Chen A, Ganor Y, Rahimipour S, Ben-Aroya N, Koch Y, Levite M. The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med 2002;8:1421–6.
  • Azad N, La Paglia N, Jurgens KA, Kirsteins L, Emanuele NV, Kelley MR Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T-lymphocytes. Endocrinology 1993;133:215–23.
  • Morale MC, Batticane N, Bartoloni G, Guarcello V, Farinella Z, Galasso MG, Blockade of central and peripheral luteinising hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses. Endocrinology 1991;128:1073–85.
  • Sabharwal P, Varma S, Malarkey WB. Human thymocytes secrete luteinising hormone: an autocrine regulator of T-cell proliferation. Biochem Biophys Res Commun 1992;187:1187–92.
  • Iqbal J, Sun L, Kumar TR, Blair HC, Zaidi M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 2006;103:14925–30.
  • Kass AS, Lea TE, Torjesen PA, Gulseth HC, Forre OT. The association of luteinizing hormone and follicle-stimulating hormone with cytokines and markers of disease activity in rheumatoid arthritis: a case-control study. Scand J Rheumatol 2010;39:109–17.
  • Pope J, Joneja M, Hong P. Anti-androgen treatment of prostatic carcinoma may be a risk factor for development of rheumatoid arthritis. J Rheumatol 2002;29:2459–62.
  • Lazúrova I, Angelovicova J, Petríkova J, Calfova A, Oetterova M, Švajdler M. A case of polymyositis and vasculitis induced by ovulation induction therapy with gonadotropin-releasing hormone. Clin Rheumatol 2010;29:1327–30.
  • Jacobson JD, Nisula BC, Steinberg AD. Modulation of the expression of murine lupus by gonadotropin-releasing hormone analogs. Endocrinology 1994;6:2516–23.
  • Ansari MA, Dhar M, Spieker S, Bakht N, Rahman AM, Moore WV, Modulation of diabetes with gonadotropin-releasing hormone antagonists in the nonobese mouse model of autoimmune diabetes. Endocrinology 2004;1:337–42.
  • Jacobsen JD, Ansari MA, Mansfield ME, McArthur CP, Clement LT. Gonadotropin-releasing hormone increases CD4+ T-lymphocyte numbers in an animal model of immunodeficiency. J Allergy Clin Immunol 1999;104:653–58.
  • Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, Controlled trial of fasting and one year vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899–902.